PROAIR HFA
SABA MDI
Albuterol sulfate · Teva Pharmaceuticals
Discontinued by manufacturer
Teva discontinued branded ProAir HFA effective October 1, 2022. An identical authorized generic (albuterol sulfate inhalation aerosol, Teva) remains available.
Teva authorized generic listingActive Medication & Mechanism
- Albuterol sulfate SABA90 mcg albuterol per actuation (108 mcg albuterol sulfate)
Short-acting beta2-adrenergic agonist. Produces rapid bronchodilation within 5 minutes by relaxing airway smooth muscle through beta2-receptor stimulation.
FDA-Approved Dosing — Strength × Indication
Strength Regimen AsthmaExercise-Induced Bronchospasm
90 mcg
Varies by indication — see columns
FDA Approved
2 inhalations every 4–6 hours as needed → As needed; 1 inhalation may suffice Treatment or prevention of bronchospasm in reversible obstructive airway disease.
FDA Approved
2 inhalations 15–30 minutes before exercise → As needed Prevention of exercise-induced bronchospasm.
All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling
90 mcg
Asthma FDA Approved
2 inhalations every 4–6 hours as needed → As needed; 1 inhalation may suffice Treatment or prevention of bronchospasm in reversible obstructive airway disease.
Exercise-Induced Bronchospasm FDA Approved
2 inhalations 15–30 minutes before exercise → As needed Prevention of exercise-induced bronchospasm.
All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling
Rescue inhaler. Indicated for acute bronchospasm and as-needed symptom relief — onset within minutes. Increasing or frequent use signals worsening asthma control and warrants controller therapy reassessment.
Related Inhalers
Same active ingredients (Albuterol)
Other SABA inhalers